Coherus Oncology, Inc. (CHRS) Gross profit 2019–2025
Coherus Oncology, Inc. (CHRS) annual gross profit history from SEC filings — each fiscal year as reported.
$28.4MFY2025 · since FY2019: $339.0M → $28.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $28.4M | +60.6% |
| FY2024 | $17.7M | -82.0% |
| FY2023 | $98.3M | -30.3% |
| FY2022 | $141.0M | -47.6% |
| FY2021 | $269.0M | -38.6% |
| FY2020 | $438.2M | +29.3% |
| FY2019 | $339.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice